ArticleFrontiers in pharmacology2024

Synergistic effects of anlotinib and DDP on breast cancer: targeting the VEGF/JAK2/STAT3 axis.

Hongmei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.